2019
French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies
Bouvard B, Confavreux CB, Briot K, Bonneterre J, Cormier C, Cortet B, Hannoun-Lévi JM, Hennequin C, Javier RM, Kerbrat P, Lespessailles E, Lesur A, Mayeur D, Paccou J, Trémollières F, Vieillard MH, Debiais F
Journal: Joint Bone Spine
Volume: 86, Issue 5
Année: Octobre 2019
Pages: 542-553
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
Tellez-Gabriel M, Heymann MF, Heymann D
Journal: Theranostics
Volume: 9, Issue 16
Année: Août 2019
Pages: 4580-4594
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors
Marcucci G, Beltrami G, Tamburini A, Body JJ, Confavreux CB, Hadji P, Holzer G, Kendler D, Napoli N, Pierroz DD, Rizzoli R, Brandi ML
Journal: Annals of Oncology
Volume: 30, Issue 6
Année: Juin 2019
Pages: 908-920
Radionuclide imaging and therapy of bone metastases in the era of targeted therapy
Van den Wyngaert T, Paycha F
Journal: Journal of Nuclear Medicine and Molecular Imaging
Volume: 63, Issue 2
Année: Juin 2019
Pages: 95
Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody
Von Moos R, Costa L, Gonzalez-Suarez E, Terpos E, Niepel D, Body JJ
Journal: Cancer Treatment Reviews
Volume: 76
Année: Juin 2019
Pages: 57-67
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
Marino S, de Ridder D, Bishop RT, Renema N, Ponzetti M, Sophocleous A, Capulli M, Aljeffery A, Carrasco G, Gens MD, Khogeer A, Ralston SH, Gertsch J, Lamoureux F, Heymann D, Rucci N, Idris AI
Journal: EBioMedicine
Volume: 44
Année: Juin 2019
Pages: 452-466
Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI
Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE
Journal: Diagnostic and Interventional Imaging
Volume: 100, Issue 5
Année: Mai 2019
Pages: 295-302
Effets osseux des traitements de bisphosphonates et dénosumab en cas de cancer du sein ou de la prostate [Bone effects of bisphosphonates and denosumab treatments in breast or prostate cancer]
Biver E
Journal: Revue Médicale Suisse
Volume: 15
Année: Avril 2019
Pages: 824-830
https://www.revmed.ch/RMS/2019/RMS-N-647/Effets-osseux-des-traitements-de-bisph…
Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management
Confavreux CB, Pialat JB, Bellière A, Brevet M, Decroisette C, Tescaru A, Wegrzyn J, Barrey C, Mornex F, Souquet PJ, Girard N
Journal: Joint Bone Spine
Volume: 86, Issue 2
Année: Mars 2019
Pages: 185-194
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors
Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin JE, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E.
Journal: Oncogene
Volume: 38, Issue 7
Année: Novembre 2019
Pages: 950-964